Issue 18 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Officials who fired Beckerle out at University of Utah as tables turn

Congress approves $2 billion increase for NIH in FY17 omnibus but FDA cancer center remains unfunded in legislative glitch

Impact of Proposed Cuts to NIH Budget:
More Than Just About Cancer

Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”

In Brief

Stephen Gruber steps down as director at USC Norris

Bhavesh Ashar named to lead U.S. oncology business at Bayer

UAB expands cancer navigation program nationally with Guideway Care

Paul Goldberg finalist for Sami Rohr Prize

Drugs & Targets

FDA grants an accelerated approval for AstraZeneca's Imfinzi for urothelial carcinoma

Draft Local Coverage Determination favorable to Oncotype DX Genomic Prostate Score

Opdivo gets European approval for squamous cell head and neck cancer

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login